Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|September 13, 2011

MRI Study Confirms Altered Brain Blood Flow in Gulf War Veterans

Author(s)Todd Neff

Blood flow abnormalities in the brains of veterans with Gulf War illness have persisted 20 years and in some cases have gotten worse, according to a new arterial spin labeled (ASL) MRI study published online in the journal Radiology.

Blood flow abnormalities in the brains of veterans with Gulf War illness have persisted 20 years and in some cases have gotten worse, according to a new arterial spin labeled (ASL) MRI study published online in the journal Radiology.

Gulf War illness is a poorly understood chronic condition associated with exposure to neurotoxic chemicals and nerve gas. It affects an estimated 25 percent of the 700,000 military personnel deployed to the 1991 Persian Gulf War, according to the U.S. Department of Veterans Affairs’ scientific advisory committee.

There are three main syndromes associated with Gulf War illness, producing a variety of symptoms, including fatigue, neuropathic pain, memory and concentration deficits, balance disturbances, and depression. Many Gulf War illness neurological symptoms, such as memory loss, confusion, irritability, and disorders in motion control suggest impairment of the hippocampus, the part of the brain responsible for forming long-term memories and helping with spatial navigation.

For the current study, the researchers used ASL MRI to assess hippocampal regional cerebral blood flow (rCBF) in 13 control participants and 35 patients with Gulf War syndromes 1 (impaired cognition), 2 (confusion-ataxia) and 3 (central neuropathic pain).

“We confirmed that abnormal blood flow continued or worsened over the 11-year span since first being diagnosed, which indicates that the damage is ongoing and lasts long term,” said principal investigator Robert W. Haley, MD, chief of epidemiology in the Departments of Internal Medicine and Clinical Sciences at the University of Texas (UT) Southwestern Medical Center in Dallas. “We also identified a special MRI procedure that better diagnoses and distinguishes between the three main types of Gulf War illness.”

Each patient received intravenous infusions of saline in an initial session, and physostigmine in a second session 48 hours later. Physostigmine is a short-acting cholinesterase inhibitor, used to test the functional integrity of the cholnergic system, a neurotransmitter system involved in the regulation of memory and learning.

“ASL scanning after giving this medication is particularly well suited to diagnosing Gulf War illness, because it picks up brain abnormalities too subtle for regular MRI to detect,” said co-author Richard W. Briggs, PhD, professor of radiology at UT Southwestern. “This allows us to make the diagnosis in a single two-hour session without the need for exposure to ionizing radiation.”

In 1998, Haley’s research team published a study using single photon emission computed tomography (SPECT) to assess hippocampal blood flow in veterans with Gulf War Syndrome. The new findings replicated the results of the initial SPECT study of largely the same group of veterans.

The results showed that abnormal hippocampal blood flow persisted and may have progressed 11 years after initial testing and nearly 20 years after the Gulf War, suggesting chronic alteration of hippocampal blood flow.

Physostigmine significantly decreased rCBF in control participants and veterans with syndrome 1, but significantly increased rCBF in the right hippocampus of veterans with syndrome 2 in the original study. The abnormal increase in rCBF was now found to have progressed to the left hippocampus with syndrome 2 and to both hippocampi of the veterans with syndrome 3.

“Having an objective diagnostic test allows researchers to identify ill veterans for future clinical trials to test possible treatments,” Haley said. “It is also critical for ongoing genomic studies to see why some people are affected by chemical exposures, and why others are not.”


Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Radiology and Building the Alzheimer’s Care Pathway of the Future
Given the increasing prevalence of Alzheimer’s disease and a staggering number of people with dementia who are undiagnosed, this author discusses five essential keys for radiologists and their colleagues to facilitate earlier detection, precision care treatment and monitoring to help ensure timely care and intervention.